The role of hypocortisolism in chronic fatigue syndrome

Psychoneuroendocrinology

Volumn 42, Issue , 2014, Pages 199-206

  Nijhof, Sanne L ^a   Rutten, Juliette M T M ^b   Uiterwaal, Cuno S P M ^c   Bleijenberg, Gijs ^d   Kimpen, Jan L L ^a   Putte, Elise M van de ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adolescents; Awakening response; Chronic fatigue; Cortisol; Recovery

Indexed keywords

HYDROCORTISONE;

ADOLESCENT; ADULT; AROUSAL; ARTICLE; CHILD; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; SALIVA LEVEL; SCHOOL CHILD;

ADOLESCENTS; AWAKENING RESPONSE; CHRONIC FATIGUE; CORTISOL; RECOVERY;

ADOLESCENT; CHILD; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; SALIVA;

EID: 84895869017     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.01.017     Document Type: Article

References (46)

1. Bell D.S., Jordan K., Robinson M. Thirteen-year follow-up of children and adolescents with chronic fatigue syndrome. Pediatrics 2001, 107:994-998.
2. Chalder T., Deary V., Husain K., Walwyn R. Family-focused cognitive behaviour therapy versus psycho-education for chronic fatigue syndrome in 11- to 18-year-olds: a randomized controlled treatment trial. Psychol. Med. 2010, 40:1269-1279.
3. Chrousos G.P., Kino T., Charmandari E. Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence. Neuroimmunomodulation 2009, 16:272-283.
4. Cleare A.J. The neuroendocrinology of chronic fatigue syndrome. Endocr. Rev. 2003, 24:236-252.
5. Cleare A.J. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol. Metab. 2004, 15:55-59.
6. Cleare A.J., Heap E., Malhi G.S., Wessely S., O'Keane V., Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999, 353:455-458.
7. Clow A., Thorn L., Evans P., Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress 2004, 7:29-37.
8. Demitrack M.A., Dale J.K., Straus S.E., Laue L., Listwak S.J., Kruesi M.J., Chrousos G.P., Gold P.W. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 1991, 73:1224-1234.
9. Federenko I., Wust S., Hellhammer D.H., Dechoux R., Kumsta R., Kirschbaum C. Free cortisol awakening responses are influenced by awakening time. Psychoneuroendocrinology 2004, 29:174-184.
10. Fekedulegn D.B., Andrew M.E., Burchfiel C.M., Violanti J.M., Hartley T.A., Charles L.E., Miller D.B. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom. Med. 2007, 69:651-659.
11. Fries E., Dettenborn L., Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int. J. Psychophysiol. 2009, 72:67-73.
12. Fries E., Hesse J., Hellhammer J., Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30:1010-1016.
13. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994, 121:953-959.
14. Garde A.H., Hansen A.M. Long-term stability of salivary cortisol. Scand. J. Clin. Lab. Invest. 2005, 65:433-436.
15. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
16. Jessop D.S., Turner-Cobb J.M. Measurement and meaning of salivary cortisol: a focus on health and disease in children. Stress 2008, 11:1-14.
17. Kley H.K., Rick W. The effect of storage and temperature on the analysis of steroids in plasma and blood. J. Clin. Chem. Clin. Biochem. 1984, 22:371-378.
18. Knoop H., Stulemeijer M., de Jong L.W., Fiselier T.J., Bleijenberg G. Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial. Pediatrics 2008, 121:e619-e625.
19. Kovacs M. The Children's Depression, Inventory (CDI). Psychopharmacol. Bull. 1985, 21:995-998.
20. Kudielka B.M., Kirschbaum C. Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psychoneuroendocrinology 2003, 28:35-47.
21. Kupper N., de Geus E.J., van den Berg M., Kirschbaum C., Boomsma D.I., Willemsen G. Familial influences on basal salivary cortisol in an adult population. Psychoneuroendocrinology 2005, 30:857-868.
22. McKenzie R., O'Fallon A., Dale J., Demitrack M., Sharma G., Deloria M., Garcia-Borreguero D., Blackwelder W., Straus S.E. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998, 280:1061-1066.
23. Nijhof S.L., Bleijenberg G., Uiterwaal C.S., Kimpen J.L., van de Putte E.M. Fatigue in Teenagers on the interNET-the FITNET Trial: a randomized clinical trial of web-based cognitive behavioural therapy for adolescents with chronic fatigue syndrome: study protocol [ISRCTN59878666]. BMC Neurol. 2011, 11. 23-2377-11-23.
24. Nijhof S.L., Bleijenberg G., Uiterwaal C.S., Kimpen J.L., van de Putte E.M. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet 2012, 379:1412-1418.
25. Nijhof S.L., Maijer K., Bleijenberg G., Uiterwaal C.S., Kimpen J.L., van de Putte E.M. Adolescent chronic fatigue syndrome: prevalence, incidence, and morbidity. Pediatrics 2011, 127:e1169-e1175.
26. Nijhof S.L., Priesterbach L.P., Uiterwaal C.S., Bleijenberg G., Kimpen J.L., van de Putte E.M. Internet-based therapy for adolescents with chronic fatigue syndrome: long-term follow-up. Pediatrics 2013, 131:e1788-e1795.
27. Papadopoulos A., Ebrecht M., Roberts A.D., Poon L., Rohleder N., Cleare A.J. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5mg) dexamethasone suppression test. J. Affective Disord. 2009, 112:289-294.
28. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28:916-931.
29. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., von Auer K., Jobst S., Kaspers F., Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 1997, 61:2539-2549.
30. Raat H., Landgraf J.M., Bonsel G.J., Gemke R.J., Essink-Bot M.L. Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual. Life Res. 2002, 11:575-581.
31. Roberts A.D., Wessely S., Chalder T., Papadopoulos A., Cleare A.J. Salivary cortisol response to awakening in chronic fatigue syndrome. Br. J. Psychiatry 2004, 184:136-141.
32. Roberts A.D., Papadopoulos A.S., Wessely S., Chalder T., Cleare A.J. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. J. Affective Disord. 2009, 115:280-286.
33. Roberts A.D., Charler M.L., Papadopoulos A., Wessely S., Chalder T., Cleare A.J. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?. Psychol. Med. 2010, 40:515-522.
34. Scheeres K., Knoop H., Meer J., Bleijenberg G. Clinical assessment of the physical activity pattern of chronic fatigue syndrome patients: a validation of three methods. Health Qual. Life Outcomes 2009, 7:29.
35. Steptoe A., Ussher M. Smoking, cortisol and nicotine. Int. J. Psychophysiol. 2006, 59:228-235.
36. Stroud L.R., Solomon C., Shenassa E., Papandonatos G., Niaura R., Lipsitt L.P., Lewinn K., Buka S.L. Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: still valid after all these years. Psychoneuroendocrinology 2007, 32:140-150.
37. Stulemeijer M., de Jong L.W., Fiselier T.J., Hoogveld S.W., Bleijenberg G. Cognitive behaviour therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. BMJ 2005, 330:14.
38. Tak L.M., Cleare A.J., Ormel J., Manoharan A., Kok I.C., Wessely S., Rosmalen J.G. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol. Psychol. 2011, 87:183-194.
39. ter Wolbeek M., van Doornen L.J., Coffeng L.E., Kavelaars A., Heijnen C.J. Cortisol and severe fatigue: a longitudinal study in adolescent girls. Psychoneuroendocrinology 2007, 32:171-182.
40. Tornhage C.J. Salivary cortisol for assessment of hypothalamic-pituitary-adrenal axis function. Neuroimmunomodulation 2009, 16:284-289.
41. van de Putte E.M., van Doornen L.J., Engelbert R.H., Kuis W., Kimpen J.L., Uiterwaal C.S. Mirrored symptoms in mother and child with chronic fatigue syndrome. Pediatrics 2006, 117:2074-2079.
42. van der Werf S.P., Prins J.B., Vercoulen J.H., van der Meer J.W., Bleijenberg G. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J. Psychosom. Res. 2000, 49:373-379.
43. van Geelen S.M., Bakker R.J., Kuis W., van de Putte E.M. Adolescent chronic fatigue syndrome: a follow-up study. Arch. Pediat. Adolesc. Med. 2010, 164:810-814.
44. Van Houdenhove B., Van Den Eede F., Luyten P. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?. Med. Hypotheses 2009, 72:701-705.
45. Vercoulen J.H., Swanink C.M., Fennis J.F., Galama J.M., van der Meer J.W., Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J. Psychosom. Res. 1994, 38:383-392.
46. Wust S., Wolf J., Hellhammer D.H., Federenko I., Schommer N., Kirschbaum C. The cortisol awakening response-normal values and confounds. Noise Health 2000, 2:79-88.